Details for New Drug Application (NDA): 020918

NDA 020918 describes GLUCAGEN, which is a drug marketed by Novo Nordisk and is included in one NDA. It is available from one supplier. Additional details are available on the GLUCAGEN profile page.

The generic ingredient in GLUCAGEN is glucagon hydrochloride. There are twelve drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the glucagon hydrochloride profile page.

Summary for 020918

Tradename:	GLUCAGEN
Applicant:	Novo Nordisk
Ingredient:	glucagon hydrochloride
Patents:	0

Suppliers and Packaging for NDA: 020918

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
GLUCAGEN	glucagon hydrochloride	POWDER;INTRAMUSCULAR, INTRAVENOUS	020918	NDA	Novo Nordisk	0169-7065	0169-7065-15	1 KIT in 1 KIT (0169-7065-15) * 1 mL in 1 VIAL, GLASS * 1 mL in 1 SYRINGE, GLASS
GLUCAGEN	glucagon hydrochloride	POWDER;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS	020918	NDA	Novo Nordisk	0169-7065	0169-7065-15	1 KIT in 1 KIT (0169-7065-15) * 1 mL in 1 VIAL, GLASS * 1 mL in 1 SYRINGE, GLASS

Profile for product number 001

Active Rx/OTC/Discontinued:	DISCN	Dosage:	POWDER;INTRAMUSCULAR, INTRAVENOUS			Strength	EQ 1MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date:	Jun 22, 1998	TE:		RLD:	Yes

Profile for product number 002

Active Rx/OTC/Discontinued:	DISCN	Dosage:	POWDER;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS			Strength	EQ 1MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date:	Jun 22, 1998	TE:		RLD:	Yes

Complete Access Available with Subscription